Debargha Basuli, MD PhD Profile
Debargha Basuli, MD PhD

@DebarghaBasuli

Followers
237
Following
108
Media
1
Statuses
73

Nephrology Asst Professor @ECUHealth_IM I Transplant Nephrology @OHSUNephrology I

Joined November 2021
Don't wanna be here? Send us removal request.
@DebarghaBasuli
Debargha Basuli, MD PhD
6 months
RT @katiewiskar: Confession: I LOVE hyponatremia 🤓. (I know, I know. What can I say, I'm a true internist!). HypoNa is often feared, malign….
0
489
0
@DebarghaBasuli
Debargha Basuli, MD PhD
7 months
RT @CJASN: Fluid overload occurs frequently in critically ill patients with AKI and is one of the indications for continuous kidney replace….
0
54
0
@DebarghaBasuli
Debargha Basuli, MD PhD
1 year
RT @KIDNEYcon: KIDNEYcon Registration is Open!.April 6-8, 2024.Little Rock, AR. Little Rock will experience the 202….
0
16
0
@DebarghaBasuli
Debargha Basuli, MD PhD
1 year
RT @AlanYuNeph: Re-reading excellent thread by.@NephroMD. In Winzeler paper, UOsm>=500 is highly specific for non-responsiveness but v. ins….
0
6
0
@DebarghaBasuli
Debargha Basuli, MD PhD
2 years
RT @edgarvlermamd: DARE-ESKD 1: Pharmacokinetic Properties of SGLT2 inhibitor (SGLT2i) Dapagliflozin in Patients on Hemodialysis and Perito….
0
143
0
@DebarghaBasuli
Debargha Basuli, MD PhD
2 years
RT @kidney_boy: Looks like you can #Flozinate your dialysis patients!. "In individuals with kidney failure on dialysis, dapagliflozin was w….
0
93
0
@DebarghaBasuli
Debargha Basuli, MD PhD
2 years
RT @KIReports: ✅IT OUT 👇.📢📢📢Tweetorial Alert (1/19)! .What is the most common complication of routine outpatient hemodialysis (HD) treatmen….
0
31
0
@DebarghaBasuli
Debargha Basuli, MD PhD
2 years
RT @GlomCon: Genomics in Glomerular Disease.A GlomCon Pubs summary on genetic diagnoses of glomerular diseases by Dr. Benjamin Tan @NephBen….
0
12
0
@DebarghaBasuli
Debargha Basuli, MD PhD
3 years
RT @KitchingLab: Our article in @NatRevImmunol proposes that nephritis can be classified primarily according to cause, then by the lesion.….
0
22
0
@DebarghaBasuli
Debargha Basuli, MD PhD
3 years
RT @jeroendebaaij: Sometimes people ask me to share some educational materials. Therefore, my Twitter guide to Gitelman Syndrome! 🫘🧬.The ke….
0
86
0
@DebarghaBasuli
Debargha Basuli, MD PhD
3 years
RT @RenalFellowNtwk: A nice refresher of high yield kidney disorders! .#TBThursday .-md.
0
1
0
@DebarghaBasuli
Debargha Basuli, MD PhD
3 years
0
1
2
@DebarghaBasuli
Debargha Basuli, MD PhD
3 years
RT @ArgaizR: Ambulatory Hemodialysis Unit Rounds:. Called to see a patient with hypotension: BP 76/40,🧠 OK, CRT 5 seconds. 1st step ➡️🛑Ultr….
0
158
0
@DebarghaBasuli
Debargha Basuli, MD PhD
3 years
RT @drraviele: 📌 A very comprehensive stepwise ECG algorithm .👉 to predict site of origin of idiopathic VAs.#ECG #CardioTwitter #EPeeps @ad….
0
270
0
@DebarghaBasuli
Debargha Basuli, MD PhD
3 years
RT @ArgaizR: #AKIConsultSeries:👨w T2DM➡️🏥 for fever, dysuria and CVA tenderness. On arrival: ⬇️BP, ⬆️Glucose, ⬆️AGMA. Dx UTI + DKA. Tx: Abx….
0
193
0
@DebarghaBasuli
Debargha Basuli, MD PhD
3 years
RT @ckd_ce: 1) Welcome to this new #accredited #tweetorial on best practices for providing #interprofessional, multidisciplinary, and multi….
0
19
0
@DebarghaBasuli
Debargha Basuli, MD PhD
3 years
RT @kidney_boy: sacubitril. any data in ESRD?. #AskRenal.
0
12
0
@DebarghaBasuli
Debargha Basuli, MD PhD
3 years
RT @ckd_ce: 1) Welcome to a new #accredited #tweetorial on the latest advances in the management of #CKD in the setting of patients with an….
0
22
0
@DebarghaBasuli
Debargha Basuli, MD PhD
3 years
RT @goKDIGO: KDIGO is pleased to announce the publication of the 2022 Diabetes Management in CKD Guideline. Read the Guideline:. https://t.….
0
332
0
@DebarghaBasuli
Debargha Basuli, MD PhD
3 years
RT @ArgaizR: 🧵Complex #Hemodynamics in ESRD:. Middle age pt ➡️ 🏥 for syncope. HPI: Low BP during HD sessions. Does not achieve dry weight.….
0
95
0